The company has not filed an annual or quarterly report since its FY2018 10-K, filed Mar 25, 2019. Its latest SEC filing is a 15-12G from Apr 29, 2019.
10-K for FY2018, filed Mar 25, 2019
The sections below describe the company as of the FY2018 annual report.
Sells monitors and adhesive sensors that help hospitals track patients’ brain and tissue oxygen levels during surgery and critical care.
10-K for FY2018, filed Mar 25, 2019We are a medical technology company that develops, manufactures, and markets non-invasive cerebral and tissue oximeters used in patient…View ↗
Our principal products are the FORE-SIGHT® and FORE-SIGHT ELITE® brand tissue oximeters and sensors. With a simple non-invasive adhesive…View ↗
Our products are typically sold to hospitals. Clinician users include anesthesiologists, perfusionists, and surgeons in an operating room…View ↗
$22.5M
10-K, filed Mar 27, 2012
$22.5M ↗
Hospitals typically buy its products; anesthesiologists, perfusionists, surgeons, intensivists and nurses use them in operating rooms and intensive care units.
10-K for FY2018, filed Mar 25, 2019Our products are typically sold to hospitals. Clinician users include anesthesiologists, perfusionists, and surgeons in an operating room…View ↗
No. It lost $6.1M in FY2011.
10-K, filed Mar 27, 2012
8-K, filed Apr 18, 2019
On April 18, 2019, the Company completed its merger with Crown Merger Sub, Inc. (“Merger Sub”), a Delaware corporation and a wholly owned…View ↗
Shrank.
Revenue fell 7% in 1 year, from $24.1M in FY2010 to $22.5M in FY2011, about 7% a year.
10-K, filed Mar 27, 2012
From legacy products to a sole focus
CASMED shifted from selling FORE-SIGHT with traditional monitoring products and neonatal supplies to focusing solely on FORE-SIGHT oximetry; disposable sensor sales account for most continuing sales.
10-K for FY2015, filed Mar 30, 2016 10-K for FY2018, filed Mar 25, 2019CASMED has completed significant product line divestitures in recent years and has successfully executed its multi-year strategic goal of…View ↗
Loading...
